Nabla has raised $70 million in Series C funding to accelerate product development, grow its clinical and commercial teams, and expand into new care environments. The round was led by HV Capital, with participation from Highland Europe, DST Global, Cathay Innovation, and Tony Fadell’s Build Collective. The latest raise brings the AI clinical assistant’s total funding to $120 million. Nabla’s AI assistant is currently used by over 85,000 clinicians across more than 130 U.S. healthcare organizations, including CVS Health, Children's Hospital Los Angeles, and the University of Iowa Health Care. The assistant integrates with major EHRs like Epic, Cerner, and athenahealth and is available in 35 languages. Nabla has seen rapid adoption, with revenue growing fivefold in six months and peer-reviewed studies showing significant reductions in clinician burnout and documentation time.
Nabla is building an Adaptive Agentic Platform to support more clinical roles and workflows. New features include a proactive coding agent, context-aware documentation, and tailored tools for nurses and inpatient settings. CEO and Co-Founder of Nabla, Alex LeBrun, said, “Clinicians already trust our accuracy and speed, and this funding allows us to expand that impact by embedding intelligent support directly into care delivery. We see a future where AI not only documents care, but actively drives efficiency by executing actions within complex clinical workflows and environments.” HV Capital Partner Alexander Joel-Carbonell added, “More than 130 Tier 1 healthcare organizations rely on Nabla, a testament to the team’s ability to pair technological excellence with deep empathy for clinicians.”
